Pura Vida Investments, LLC In its 13F for Q4 2024 (holdings as of December 31, 2024, filed February 12, 2025), Pura Vida Investments, LLC reported 9 stock positions worth $18.1 million . Its top holding was Establishment Labs (ESTA) at 28.8% of the portfolio, followed by Advisorshares Pure US Cann (MSOS, 15.8% ) and Pulmonx (LUNG, 14.5% ). Compared with Q3 2024, it sold out of 7, added to 1 and reduced 7. The biggest buy was Insight Molecular Diagnostic (IMDX, shares +32% ) and the biggest sale an exit from Glaukos (GKOS).
Location NEW YORK, NY
CIK 0001590144
Portfolio Value $18.1M (Q4 2024) Holdings 9 stocks · $18.1M Holdings quarter Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024
Stock % Of Portfolio ▼ Shares Held Total Value Change vs Q3 2024 ESTA Establishment Labs Holdings 113,041 $5.2M Reduce -41.1% MSOS Advisorshares Pure US Cann 750,000 $2.9M Reduce -53.8% LUNG Pulmonx Corp. 387,200 $2.6M Reduce -24.0% QTRX Quanterix Corp. 234,755 $2.5M Reduce -33.1% IMDX Insight Molecular Diagnostic filed as ONCOCYTE CORP 654,451 $1.6M Add +32.1% NSPR Inspiremd Inc. 450,517 $1.2M No change MGX Metagenomi Therapeutics Inc. 264,391 $954K Reduce -2.3% NTRA Natera Inc. 5,000 $792K Reduce -88.5% CUTRQ Cutera Inc. 1,141,009 $403K Reduce -2.1%
Options reported separately and not counted above: ISRG calls ($1.8M), GKOS calls ($1.8M), PPH puts ($1.7M), NTRA calls ($1.6M), BVS calls ($1.6M), ICUI calls ($1.6M), IHI puts ($1.2M), INMD puts ($835K), QTRX calls ($797K), CSTL calls ($666K).
Portfolio Sells Q3 2024 → Q4 2024 Portfolio Sells quarter Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024
Stock Change vs Q3 2024 % Of Portfolio Change To Portfolio ▲ GKOS Glaukos Corp. Sold out 0.00% −9.43 ISRG Intuitive Surgical Inc. Sold out 0.00% −8.24 BVS Bioventus Inc. Class A Sold out 0.00% −6.93 ICUI Icu Medical Inc. Sold out 0.00% −6.74 NTRA Natera Inc. Reduce -88.5% 4.38% −4.70 MSOS Advisorshares Pure US Cann Reduce -53.8% 15.80% −3.33 CSTL Castle Biosciences Inc. Sold out 0.00% −2.95 BRKR Bruker Corp. Sold out 0.00% −2.04 ZIMV Zimvie Inc. Sold out 0.00% −0.60 CUTRQ Cutera Inc. Reduce -2.1% 2.23% +0.72 MGX Metagenomi Therapeutics Inc. Reduce -2.3% 5.28% +4.31 QTRX Quanterix Corp. Reduce -33.1% 13.80% +6.33 LUNG Pulmonx Corp. Reduce -24.0% 14.54% +7.59 ESTA Establishment Labs Holdings Reduce -41.1% 28.80% +15.15
Portfolio Buys Q3 2024 → Q4 2024 Portfolio Buys quarter Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024
Stock Change vs Q3 2024 % Of Portfolio Change To Portfolio ▼ IMDX Insight Molecular Diagnostic Add +32.1% 8.61% +6.29
Options Activity Q3 2024 → Q4 2024 Security Type Change vs Q3 2024 Underlying Shares Value ▼ IWM iShares Russell 2000 ETF put Sold out 40,000 $8.8Mbefore exit SPY SS SPDR S&P 500 ETF Trust-US put Sold out 15,000 $8.6Mbefore exit QQQ Invesco QQQ Trust Series 1 put Sold out 15,000 $7.3Mbefore exit COO The Cooper Cos Inc. call Sold out 60,000 $6.6Mbefore exit INSP Inspire Medical Systems Inc. call Sold out 30,000 $6.3Mbefore exit WAT Waters Corp. put Sold out 17,500 $6.3Mbefore exit XBI SS SPDR S&P Biotech ETF put Sold out 50,000 $4.9Mbefore exit ZBH Zimmer Biomet Holdings Inc. put Sold out 45,000 $4.9Mbefore exit ZTS Zoetis Inc. put Sold out 20,000 $3.9Mbefore exit MDT Medtronic PLC put Sold out 40,000 $3.6Mbefore exit SYK Stryker Corp. put Sold out 9,000 $3.3Mbefore exit LLY Eli Lilly & Co. put Sold out 3,000 $2.7Mbefore exit GH Guardant Health Inc. put Sold out 115,000 $2.6Mbefore exit PRCT Procept Biorobotics Corp. put Sold out 25,000 $2.0Mbefore exit ARKG ARK Genomic Revolution ETF put Sold out 75,000 $1.9Mbefore exit ISRG Intuitive Surgical Inc. call New 3,500 $1.8M GKOS Glaukos Corp. call New 12,000 $1.8M PPH Vaneck Pharmaceutical ETF put New 20,000 $1.7M NTRA Natera Inc. call New 10,000 $1.6M BVS Bioventus Inc. Class A call New 150,000 $1.6M ICUI Icu Medical Inc. call Reduce -33.3% 10,000 $1.6M ELAN Elanco Animal Health Inc. call Sold out 100,000 $1.5Mbefore exit TNDM Tandem Diabetes Care Inc. call Sold out 30,000 $1.3Mbefore exit IHI iShares U.S. Medical Devices put Reduce -86.7% 20,000 $1.2M BAX Baxter International Inc. call Sold out 30,000 $1.1Mbefore exit INMD Inmode Ltd. put Reduce -16.7% 50,000 $835K QTRX Quanterix Corp. call New 75,000 $797K CSTL Castle Biosciences Inc. call Reduce -50.0% 25,000 $666K MMM 3M Co. call Sold out 4,000 $547Kbefore exit DCGO Docgo Inc. put Sold out 100,000 $332Kbefore exit
Calls and puts are listed by the shares they cover; their value is not part of the stock holdings above.
Notes & Other Activity Q3 2024 → Q4 2024 Security Class Change vs Q3 2024 Shares / Principal Value ▼ TALKW Hudson Executive Inv -CW25 *W EXP 06/21/202 Sold out 238,500 $19Kbefore exit MAPSW WM Technology Inc.-CW24 *W EXP 06/16/202 Sold out 50,000 $1Kbefore exit
Bonds, preferreds, convertibles and warrants; not part of the stock holdings or percentages above.
All Filings Quarter Positions 13F Reported Value Top Holdings Q2 2026 19 $37.0M ALMR, BBNX, ESTA, IMDX, NVDA Q1 2026 17 $14.9M IMDX, BBNX, ESTA, CAI, NSPR Q4 2025 18 $26.8M BBNX, IMDX, ESTA, CAI, NSPR Q3 2025 8 $16.4M BBNX, IMDX, CAI, ESTA, NSPR Q2 2025 8 $16.6M BBNX, IMDX, CAI, ESTA, OM Q1 2025 8 $13.7M BBNX, IMDX, ESTA, NSPR, KMTS Q4 2024 9 $18.1M ESTA, MSOS, LUNG, QTRX, IMDX Q3 2024 16 $60.8M MSOS, ESTA, GKOS, NTRA, ISRG Q2 2024 25 $82.7M ESTA, GKOS, ISRG, NTRA, MSOS Q1 2024 30 $146.8M EXAS, ESTA, ISRG, QTRX, LYRA